date:Aug 01, 2013
September 2010 and had hoped to complete the deal in early 2011. But opponents convinced regulators in South Africa to initially deny DuPont's bid.
The critics argued that allowing foreign corporate control of South Africa's seed supply would erode availability of traditional seed varieties, hurt export business with countries opposed to the biotech crops that DuPont develops, and force farmers deep into debt to pay for expensive seeds that are the patented properties of the U.S. corporations.